Related references
Note: Only part of the references are listed.Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
Patrick Rossignol et al.
CIRCULATION (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Serum Potassium Levels and Mortality in Acute Myocardial Infarction
Abhinav Goyal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee
Javed Butler et al.
JOURNAL OF CARDIAC FAILURE (2012)
Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure Results From the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) Study
Karl Swedberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
Akshay S. Desai et al.
AMERICAN HEART JOURNAL (2011)
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
Gregg C. Fonarow et al.
AMERICAN HEART JOURNAL (2011)
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone
Natalia Lopez-Andres et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
The 2011 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care
Robert S. McKelvie et al.
CANADIAN JOURNAL OF CARDIOLOGY (2011)
Aldosterone, Mineralocorticoid Receptor Activation, and Cardiovascular Remodeling
Jane A. Leopold
CIRCULATION (2011)
Physiology of aldosterone and pharmacology of aldosterone blockers
Allan D. Struthers et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2011)
Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction
Robin A. P. Weir et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure
John J. V. McMurray
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic
Sorel Goland et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2011)
Aldosterone Antagonists in Heart Failure
Maya Guglin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
Hari K. Parthasarathy et al.
JOURNAL OF HYPERTENSION (2011)
Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy
Patrick Rossignol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
Leah Iles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Jean-Philippe Bertocchio et al.
KIDNEY INTERNATIONAL (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study
Tony Antoniou et al.
BRITISH MEDICAL JOURNAL (2011)
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
Farzin Beygui et al.
AMERICAN HEART JOURNAL (2010)
Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure
Masayuki Yamaji et al.
AMERICAN HEART JOURNAL (2010)
Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model
Mera Stein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Aldosterone Receptor Antagonists Effective but Often Forgotten
Bradley A. Maron et al.
CIRCULATION (2010)
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
Gregg C. Fonarow et al.
CIRCULATION (2010)
Randomized, Double- Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction
James E. Udelson et al.
CIRCULATION-HEART FAILURE (2010)
Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease Findings From Propensity-Matched Studies
C. Barrett Bowling et al.
CIRCULATION-HEART FAILURE (2010)
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America
JOURNAL OF CARDIAC FAILURE (2010)
Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition A Meta-Analysis
Markus P. Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure
Andrea Kuenzli et al.
PLOS ONE (2010)
Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure
Larisa H. Cavallari et al.
PHARMACOTHERAPY (2010)
Spironolactone use and renal toxicity: population based longitudinal analysis
Li Wei et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study
Wafae Iraqi et al.
CIRCULATION (2009)
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
Sankar D. Navaneethan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials
Justin A. Ezekowitz et al.
EUROPEAN HEART JOURNAL (2009)
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results
Alessandro Boccanelli et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure
A. Brent Alper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Use of Aldosterone Antagonists in Heart Failure
Nancy M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Sharon Ann Hunt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Valsartan for Prevention of Recurrent Atrial Fibrillation
Marcello Disertori et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt et al.
CIRCULATION (2008)
A comparison of the aldosterone-blocking agents eplerenone and spironolactone
Allan Struthers et al.
CLINICAL CARDIOLOGY (2008)
Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS
J. H. O'Keefe et al.
DIABETES OBESITY & METABOLISM (2008)
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles
K. Swaminathan et al.
DIABETOLOGIA (2008)
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone
Paul Mulder et al.
EUROPEAN HEART JOURNAL (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Kenneth Dickstein et al.
EUROPEAN HEART JOURNAL (2008)
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
R. A. P. Weir et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Prediction of mode of death in heart failure the seattle heart failure model
Dariush Mozaffarian et al.
CIRCULATION (2007)
Drug Insight: aldosterone-receptor antagonists in heart failure - the journey continues
Srinivasa R. Kalidindi et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure
Ali Ahmed et al.
EUROPEAN HEART JOURNAL (2007)
Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure
Guelmisal Gueder et al.
CIRCULATION (2007)
Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: Are we monitoring for hyperkalemia?
Marsha A. Raebel et al.
ANNALS OF PHARMACOTHERAPY (2007)
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
Ravi G. Assomull et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
Murray Epstein et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
Kishlay Anand et al.
AMERICAN HEART JOURNAL (2006)
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Anique Ducharme et al.
AMERICAN HEART JOURNAL (2006)
Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction
P Di Pasquale et al.
AMERICAN HEART JOURNAL (2005)
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
P Milliez et al.
EUROPEAN HEART JOURNAL (2005)
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure
B Pitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Aldosterone synthase inhibitor ameliorates angiotensin II - Induced organ damage
A Fiebeler et al.
CIRCULATION (2005)
Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias
A Ouvrard-Pascaud et al.
CIRCULATION (2005)
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT)
AP Maggioni et al.
AMERICAN HEART JOURNAL (2005)
Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis
D Sica
HEART FAILURE REVIEWS (2005)
Aldosterone target organ protection by eplerenone
AE Rudolph et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes
JI Davies et al.
DIABETOLOGIA (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
M Svensson et al.
JOURNAL OF CARDIAC FAILURE (2004)
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment
JE Macdonald et al.
HEART (2004)
Aldosterone in the development and progression of renal injury
NK Hollenberg
KIDNEY INTERNATIONAL (2004)
Distinguishing the antihypertensive and electrolyte effects of eplerenone
DG Levy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction
M Hayashi et al.
CIRCULATION (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure
G Suzuki et al.
CIRCULATION (2002)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
MH Weinberger et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Treatment of congestive heart failure - Interfering the aldosterone-cardiac extracellular matrix relationship
F Zannad et al.
HYPERTENSION (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
Preserving renal function in adults with hypertension and diabetes: A consensus approach
GL Bakris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Aldosterone and myocardial fibrosis in heart failure
CG Brilla
HERZ (2000)
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
CAJ Farquharson et al.
CIRCULATION (2000)
Share Paper
